Sat 17 Oct 2026

Beta version

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

Ensure the website is using the HTTPS protocol.

Registered with the Digital Government Authority under number:

Drug Approvals

SFDA Approved Use	Aripiprazole is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older Aripiprazole is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment Aripiprazole is indicated for the treatment up to 12 weeks of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged 13 years and older